Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Sensorial Evaluation of Eslicarbazepine Acetate Oral Suspension

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: ALMEIDA, Hugo (Bial - Portela & Cª, S.A., R&D Department - Pharmaceutical Development, Coronado (S. Romão e S. Mamede), Portugal)
  • Co-author(s): Hugo Miguel Almeida: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
    Teofilo Vasconcelos: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
    Ricardo Lima: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
    Patrício Soares-da-Silva: R&D Department - Pharmaceutical Development, Bial - Portela & Cª, S.A., Coronado (S. Romão e S. Mamede), Portugal
  • Abstract:

    Backgrounds

    Sensorial evaluation of an oral suspension is a critical parameter in the development of this oral dosage form.

    Aims

    To describe the study conducted to assess palatability and acceptability by adult humans of eslicarbazepine acetate oral suspension.

    Methods

    Two adult panels were submitted to the study: one in Europe (7 males + 7 females)

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses